LVMH Moët Hennessy Louis Vuitton SA Stock News

Bernard Arnault – the Chief Executive of LVMH is being investigated on financial transactions involving Nikolai Sarkisov. Who is Nikolai Sarkisov?

The Paris public prosecutor's office is investigating LVMH CEO Bernard Arnault over financial transactions involving Russian oligarch Nikolai Sarkisov.

Jon Cox, head of European consumer equities at Kepler Cheuvreux believes there are many "very, very cheap" stocks right now in the luxury sector after many were "bashed up" over the summer.

Luxury retail stocks, such as brands LVMH (MC.PA), Kering (KER.PA), and Richemont (CFR.SW), have fallen off tremendously, reversing their year-to-date profit gains. Morgan Stanley analysts have decrea

Nomalisimg demand across the global luxury goods market has left Bank of America analysts backing those with a more affluent customer base. Including Hermes, Louis Vuitton Moet Hennessey, Brunello Cuc

The thing about bear markets is they are so short-lived. Since 1928, the average bear market lasted just 15 months.

U.S. investors know how successful a strategy of investing in the S&P 500 through an index fund has been, especially as large technology companies have led such strong growth over the past decade. But

CNBC's Robert Frank with Andrew Slimmon, senior portfolio manager at Morgan Stanley Investment Management, join 'The Exchange' to discuss U.S.-China luxury consumer spending and trends.

The four major indices have not been in lock-step, but are all down month to date: the Dow -1.22%, the S&P 500 -1.51%, the Nasdaq -1.46% and the small-cap Russell 2000 -2.42%.

Novo Nordisk is now the biggest company in Europe with a valuation of more than $425 billion. The biotech company has taken over luxury goods maker LVMH in market cap size.

LVMH has a strategic advantage in the luxury market due to its successful acquisitions and ability to elevate brands through pricing and diversification. LVMH focuses on preserving craftsmanship and m

Novo Nordisk has been trading places with LVMH for the title of Europe's most valuable company. The Danish pharmaceutical giant makes the buzzy weight-loss drugs Wegovy and Ozempic.

LVMH, which has been Europe's most valuable company for two-and-a-half years, was briefly overtaken on Friday by Ozempic maker Novo Nordisk.

In the exhilarating investment realm, luxury stocks to buy are shining again on the radars of savvy investors. Inflation has taken a backseat, and with recessionary blues fading, the affluent are once

Kohl's Reports; Sephora Is Big Driver Kohl's reported second quarter sales and earnings.